The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 4 rounds in the feed, most often at Series B.
We are a global healthcare specialist, with a multi-strategy investment platform covering venture capital, private equity and public equity strategies.
Venture capitalvivocapital.comRounds from 2025-12-08 to 2026-05-18
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Full Full-Life Technologies Limited sells radiopharmaceuticals and related technologies primarily to healthcare providers. | Series D Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2026-05-18 | [ LEAD ] |
Oricell Oricell develops cell therapies specifically aimed at treating cancer patients, particularly through advanced CAR-T technology. |
Growth Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. |
| $110M |
| 2026-04-09 |
| [ LEAD ] |
Kinaset Therapeutics Developing inhaled therapeutics for respiratory diseases, specifically targeting severe asthma patients. | Series B Verified against 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $103M | 2026-01-10 | [ PART ] |
SanegeneBio Innovative RNAi therapeutics for chronic diseases, targeting autoimmune, cardiovascular, obesity, and metabolic diseases for healthcare providers and researchers. | Series B Verified against 1 source[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $110M | 2025-12-08 | [ PART ] |